Repligen (RGEN)
(Real Time Quote from BATS)
$164.88 USD
-0.01 (-0.01%)
Updated May 10, 2024 01:22 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Company Summary
Waltham, MA-based Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies.
Repligen earns revenues from the sale of several products, which can be categorized mainly under four segments — Filtration, Chromatography, Process Analytics and Protein products. The chromatography products include OPUS and OPUS PD chromatography columns, chromatography resins and ELISA test kits. Filtration products consist of XCell Alternating Tangential Flow (ATF) Systems and consumables, KrosFlo filtration products ...
Company Summary
Waltham, MA-based Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies.
Repligen earns revenues from the sale of several products, which can be categorized mainly under four segments — Filtration, Chromatography, Process Analytics and Protein products. The chromatography products include OPUS and OPUS PD chromatography columns, chromatography resins and ELISA test kits. Filtration products consist of XCell Alternating Tangential Flow (ATF) Systems and consumables, KrosFlo filtration products and SIUS filtration products. Protein products comprise the Protein A ligands and cell culture growth factors.
The company acquired privately held bioprocess analytics company C Technologies in 2019. The acquisition marked Repligen’s entry into process analytics and added its fourth franchise by the name process analytics products.
Repligen has made a few promising acquisitions in the past couple of years to diversify its business or boost its core competencies. The company has acquired New York-based Engineered Molding Technology and Non-Metallic Solutions and privately held ARTeSYN Biosolutions. Repligen also acquired Polymem, followed by Avitide and Bio-Flex Solutions. In October 2023, the company acquired Metenova AB, a privately held Swedish company.
The company reported total revenues of $639 million in 2023, down 20% year over year.
General Information
Repligen Corporation
41 SEYON STREET BUILDING 1 SUITE 100
WALTHAM, MA 02453
Phone: 781-250-0111
Fax: 781-250-0115
Email: investors@repligen.com
Industry | Medical - Biomedical and Genetics |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 3/31/2024 |
Exp Earnings Date | 8/7/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.33 |
Current Year EPS Consensus Estimate | 1.46 |
Estimated Long-Term EPS Growth Rate | 20.60 |
Exp Earnings Date | 8/7/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 164.89 |
52 Week High | 211.13 |
52 Week Low | 110.45 |
Beta | 1.03 |
20 Day Moving Average | 545,498.56 |
Target Price Consensus | 200.64 |
4 Week | -6.36 |
12 Week | -19.97 |
YTD | -8.29 |
4 Week | -6.62 |
12 Week | -22.80 |
YTD | -16.11 |
Shares Outstanding (millions) | 55.88 |
Market Capitalization (millions) | 9,213.38 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 113.27 |
Trailing 12 Months | 120.36 |
PEG Ratio | 5.51 |
vs. Previous Year | -56.25% |
vs. Previous Quarter | -15.15% |
vs. Previous Year | -17.14% |
vs. Previous Quarter | -2.82% |
Price/Book | 4.68 |
Price/Cash Flow | 54.49 |
Price / Sales | 15.17 |
3/31/24 | 3.95 |
12/31/23 | 5.00 |
9/30/23 | 6.08 |
3/31/24 | 2.90 |
12/31/23 | 3.78 |
9/30/23 | 4.69 |
3/31/24 | 6.35 |
12/31/23 | 7.02 |
9/30/23 | 2.69 |
3/31/24 | 5.24 |
12/31/23 | 5.75 |
9/30/23 | 2.11 |
3/31/24 | 12.83 |
12/31/23 | 15.40 |
9/30/23 | 17.73 |
3/31/24 | 2.44 |
12/31/23 | 6.51 |
9/30/23 | 17.29 |
3/31/24 | 4.96 |
12/31/23 | 10.04 |
9/30/23 | 18.79 |
3/31/24 | 35.27 |
12/31/23 | 35.31 |
9/30/23 | 35.62 |
3/31/24 | 1.63 |
12/31/23 | 1.57 |
9/30/23 | 1.52 |
3/31/24 | 0.26 |
12/31/23 | 0.26 |
9/30/23 | 0.00 |
3/31/24 | 20.68 |
12/31/23 | 20.56 |
9/30/23 | 0.00 |